10x Genomics Operating Income 2018-2024 | TXG

10x Genomics operating income from 2018 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
10x Genomics Annual Operating Income
(Millions of US $)
2023 $-265
2022 $-168
2021 $-52
2020 $-534
2019 $-31
2018 $-111
2017 $-18
10x Genomics Quarterly Operating Income
(Millions of US $)
2024-09-30 $-41
2024-06-30 $-42
2024-03-31 $-61
2023-12-31 $-55
2023-09-30 $-95
2023-06-30 $-63
2023-03-31 $-52
2022-12-31 $-23
2022-09-30 $-40
2022-06-30 $-63
2022-03-31 $-42
2021-12-31 $-16
2021-09-30 $-16
2021-06-30 $-10
2021-03-31 $-10
2020-12-31 $-410
2020-09-30 $-65
2020-06-30 $-39
2020-03-31 $-20
2019-12-31 $-8
2019-09-30 $-9
2019-06-30 $-10
2019-03-31 $-3
2018-12-31
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.816B $0.619B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.870B 55.80
Tempus AI (TEM) United States $9.036B 0.00
Hims & Hers Health (HIMS) United States $8.145B 207.11
Inspire Medical Systems (INSP) United States $5.799B 180.84
IRhythm Technologies (IRTC) United States $3.407B 0.00
Privia Health (PRVA) United States $2.742B 228.50
Enovis (ENOV) United States $2.671B 17.80
Azenta (AZTA) United States $2.470B 131.83
Clover Health Investments (CLOV) United States $2.200B 0.00
Omnicell (OMCL) United States $2.084B 68.17
Schrodinger (SDGR) United States $1.827B 0.00
Phreesia (PHR) United States $1.654B 0.00
Butterfly Network (BFLY) United States $0.850B 0.00
Standard BioTools (LAB) United States $0.577B 0.00
Talkspace (TALK) United States $0.524B 0.00
Fulgent Genetics (FLGT) United States $0.509B 0.00
TruBridge (TBRG) United States $0.370B 107.91
Nyxoah SA (NYXH) Belgium $0.368B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.229B 0.00
Pulmonx (LUNG) United States $0.224B 0.00
American Well (AMWL) United States $0.165B 0.00
MDxHealth SA (MDXH) Belgium $0.090B 0.00
EUDA Health Holdings (EUDA) Singapore $0.087B 0.00
P3 Health Partners (PIII) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
CareCloud (CCLD) United States $0.056B 0.00
111 (YI) China $0.050B 0.00
SHL Telemedicine (SHLT) Israel $0.047B 0.00
Outset Medical (OM) United States $0.043B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00